STAT October 18, 2024
AbbVie finally won FDA approval for its advanced Parkinson’s disease therapy
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, so far, rather modest. We expect to tidy up around the increasingly leafy Pharmalot campus, promenade with the official mascots, and catch up on our reading. We also hope to hold another listening party with Mrs. Pharmalot and the rotation will likely include this, this, this, this and this. And what about you? Once again, we maintain there is no better time to enjoy the great outdoors. And as seasonal festivities approach, you could start searching...
Today's Sponsors
Today's Sponsor